Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinoma.

Tannir NM, Plimack E, Ng C, Tamboli P, Bekele NB, Xiao L, Smith L, Lim Z, Pagliaro L, Araujo J, Aparicio A, Matin S, Wood CG, Jonasch E.

Eur Urol. 2012 Dec;62(6):1013-9. doi: 10.1016/j.eururo.2012.06.043. Epub 2012 Jun 27.

2.

Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome.

Garcia-Manero G, Tambaro FP, Bekele NB, Yang H, Ravandi F, Jabbour E, Borthakur G, Kadia TM, Konopleva MY, Faderl S, Cortes JE, Brandt M, Hu Y, McCue D, Newsome WM, Pierce SR, de Lima M, Kantarjian HM.

J Clin Oncol. 2012 Jun 20;30(18):2204-10. doi: 10.1200/JCO.2011.38.3265. Epub 2012 May 14.

3.

Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy.

Joseph RW, Peddareddigari VR, Liu P, Miller PW, Overwijk WW, Bekele NB, Ross MI, Lee JE, Gershenwald JE, Lucci A, Prieto VG, McMannis JD, Papadopoulos N, Kim K, Homsi J, Bedikian A, Hwu WJ, Hwu P, Radvanyi LG.

Clin Cancer Res. 2011 Jul 15;17(14):4882-91. doi: 10.1158/1078-0432.CCR-10-2769. Epub 2011 Jun 1.

4.

A modular Phase I study of lenalidomide and paclitaxel in metastatic castration-resistant prostate cancer following prior taxane therapy.

Mathew P, Tannir N, Tu SM, Carter CM, Bekele NB, Pagliaro L.

Cancer Chemother Pharmacol. 2010 Mar;65(4):811-5. doi: 10.1007/s00280-009-1237-9. Epub 2010 Jan 6.

5.

3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC).

Yendamuri S, Vaporciyan AA, Zaidi T, Feng L, Fernandez R, Bekele NB, Hofstetter WL, Jiang F, Mehran RJ, Rice DC, Spitz MR, Swisher SG, Walsh GL, Roth JA, Katz RL.

J Thorac Oncol. 2008 Sep;3(9):979-84. doi: 10.1097/JTO.0b013e3181834f3a.

6.

Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death.

Alonso MM, Jiang H, Yokoyama T, Xu J, Bekele NB, Lang FF, Kondo S, Gomez-Manzano C, Fueyo J.

Mol Ther. 2008 Mar;16(3):487-93. doi: 10.1038/sj.mt.6300400. Epub 2008 Feb 5.

8.

Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo.

Alonso MM, Gomez-Manzano C, Jiang H, Bekele NB, Piao Y, Yung WK, Alemany R, Fueyo J.

Cancer Gene Ther. 2007 Aug;14(8):756-61. Epub 2007 Jun 8.

PMID:
17557108
9.

Alterations in the mitochondrial displacement loop in lung cancers.

Suzuki M, Toyooka S, Miyajima K, Iizasa T, Fujisawa T, Bekele NB, Gazdar AF.

Clin Cancer Res. 2003 Nov 15;9(15):5636-41.

Supplemental Content

Loading ...
Support Center